$APOG

APOGEE ENTERPRISES, INC. (APOG): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

APOGEE ENTERPRISES, INC. (APOG) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. apog-20260805 0000006845 false 0000006845 2024-09-24 2024-09-24 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported):

Original reporting
Published Aug 5, 2026, 9:27 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 5, 2026, 9:30 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$APOG
Neutral
medium confidence
Mentioned
$APOG
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$APOGNeutralLow
01

Why it matters

The disclosure provides concrete terms for two new independent directors, including restricted stock awards and retainer eligibility, but does not include any financial or strategic commitments.

02

Market read

Traders may treat this as governance housekeeping with limited fundamental impact unless follow-on committee assignments or strategy updates emerge.

03

What to watch

Committee assignments are not yet determined; future amendments could add incremental disclosure that matters for governance-focused investors.

Relevance 6/10Novelty 5/10Timing: filed after-hours on Aug 5, 2026, for immediate governance/positioning read-through

Background

The company filed an SEC Form 8-K under Item 5.02 for director elections and related non-employee director compensation.

Company-level read

Ticker impact

$APOGNeutralMedium confidence
Context

Apogee Enterprises elected Joseph B. Hayek and Suresh Krishna as independent directors, with time-based restricted stock awards disclosed in the 8-K.

Expected impact

Low likelihood of sustained price repricing; any reaction is likely limited to governance sentiment and short-term positioning.

Evidence & confidence

The filing discloses director appointments and compensation terms, but no operational guidance, financial results, or strategic transaction is announced.

Market effects

Minimal sector read-through; this is company-specific governance news without disclosed strategy changes.

No clear regional impact beyond Nasdaq-listed sentiment.

No global relevance indicated.

Counterpoint

Director elections may be a signal of upcoming committee changes or strategic review, but the 8-K provides no such specifics yet.

Key entities

  • Apogee Enterprises, Inc.

    Nasdaq-listed company filing the 8-K for director elections and non-employee director compensation.

  • Joseph B. Hayek

    Elected Class II independent director, term expiring at the 2027 annual meeting; also described as CEO of Worthington Enterprises since Nov 2024.

  • Suresh Krishna

    Elected Class III independent director, term expiring at the 2028 annual meeting; also described as CEO of Proto Labs since May 2025.

Related articles

$APOGMedAI 8/10

Apogee to buy Luca Mariano Distillery for $19.5m

Apogee 21 (A21 Wine & Spirits) says it was selected as the successful bidder in a Chapter 11 court sale to buy Luca Mariano Distillery for $19.5m, including a 529-acre campus, assets, and about 6,600 ageing Bourbon barrels. The company plans to fund the purchase via $7m from investors, senior secured debt, and other financing, plus a $20m Series D. It also signed an LOI to buy Rod & Hammer’s whiskey brand and distillery in California.

$APOGMed

APOGEE ENTERPRISES, INC. (APOG): Completion of Acquisition or Disposition of Assets

APOGEE ENTERPRISES, INC. (APOG) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. apog-20260701 0000006845 false 0000006845 2024-11-04 2024-11-04 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported):

$APOGMed

Apogee (APOG) Q1 2027 Earnings Call Transcript

Apogee’s Q1 FY2027 earnings call said net sales fell 1.1% to $343M as lower metals and glass volume was partly offset by pricing and mix. Adjusted EBITDA margin fell to 9.4% (from 9.9%); adjusted diluted EPS rose to $0.57. Backlog ended at $735M (+8% YoY). The company cited rising input costs, pricing actions, and softer glass conditions, and reiterated full-year guidance of $1.38B–$1.43B net sales and $2.70–$3.25 adjusted EPS. Apogee expects Kalwall acquisition revenue of ~$85M at ~15% adjusted

$APOGMedAI 8/10

Why Is Apogee Enterprises Stock Soaring Friday? - Apogee Enterprises (NASDAQ:APOG)

Apogee Enterprises reported Q1 adjusted diluted EPS of 57 cents, above the 45-cent consensus, on net sales of $342.7 million versus $333.8 million expected. The company cited pricing/product mix for offsetting a 1.1% volume decline. Operating income rose to $18.8 million; operating margin to 5.5%. It kept fiscal 2027 adjusted EPS guidance of $2.70–$3.25 and sales outlook of $1.38–$1.43 billion; Kalwall acquisition remains on track for early July. Shares were up 9.44% to $46.49.

$APOGMed

APOGEE ENTERPRISES, INC. (APOG): Results of Operations and Financial Condition

APOGEE ENTERPRISES, INC. (APOG) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 a53026fy27q1results.htm EX-99.1 Document Press Release FOR RELEASE: June 26, 2026 APOGEE ENTERPRISES REPORTS FISCAL 2027 FIRST QUARTER RESULTS • First-quarter net sales of $342.7 million • First-quarter diluted EPS of $0.54 and adjusted diluted EPS of $0.57 • Pending Ka

$GOOGMed

Dow Jones still in the green but Nasdaq drops as hawkish Fed still looms

US stocks opened with the Dow up about 0.5% and the S&P 500 up just over 0.3%, while the Nasdaq was flat as investors took profits in tech. Alphabet fell 5.5% after losing AI researcher Noam Shazeer to OpenAI. AbbVie agreed to buy Apogee for ~$10.9B cash ($135.11/share). Oil eased as traders expected US-Iran supply disruptions to lessen; core PCE and Micron earnings are key this week.